Skip to content
10-Q

Quarterly Report

Kiniksa Pharmaceuticals International, plc KNSA

0001104659-25-103180

← back to feed
Filed
Oct 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 80.04M sh
Shares Diluted Q3 2025 · Sep 30, 2025 78.03M sh
Shares Diluted Q3 2025 · Sep 30, 2024 71.73M sh
Shares Diluted Q3 2025 · Sep 30, 2024 71.12M sh
Capex Q3 2025 · Sep 30, 2025 $935K
Capex Q3 2025 · Sep 30, 2024 $84K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $84.09M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $6.92M
Short Term Investments Q3 2025 · Sep 30, 2025 $177.24M
Short Term Investments Q3 2025 · Dec 31, 2024 $60.05M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $174.86M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $183.58M
Stockholders Equity Q3 2025 · Sep 30, 2025 $535.38M
Stockholders Equity Q3 2025 · Jun 30, 2025 $495.01M
Stockholders Equity Q3 2025 · Mar 31, 2025 $457.49M
Stockholders Equity Q3 2025 · Dec 31, 2024 $438.44M
Stockholders Equity Q3 2025 · Sep 30, 2024 $437.01M
Stockholders Equity Q3 2025 · Jun 30, 2024 $435.1M
Stockholders Equity Q3 2025 · Mar 31, 2024 $431.9M
Stockholders Equity Q3 2025 · Dec 31, 2023 $438.84M
Current Liabilities Q3 2025 · Sep 30, 2025 $123.59M
Current Liabilities Q3 2025 · Dec 31, 2024 $100.62M
Total Liabilities Q3 2025 · Sep 30, 2025 $176.95M
Total Liabilities Q3 2025 · Dec 31, 2024 $142.12M
Current Assets Q3 2025 · Sep 30, 2025 $475.53M
Current Assets Q3 2025 · Dec 31, 2024 $331.8M
Total Assets Q3 2025 · Sep 30, 2025 $712.33M
Total Assets Q3 2025 · Dec 31, 2024 $580.55M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.23
Eps Diluted Q3 2025 · Sep 30, 2025 $0.57
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.18
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.48
Eps Basic Q3 2025 · Sep 30, 2025 $0.25
Eps Basic Q3 2025 · Sep 30, 2025 $0.61
Eps Basic Q3 2025 · Sep 30, 2024 −$0.18
Eps Basic Q3 2025 · Sep 30, 2024 −$0.48
Sga Expense Q3 2025 · Sep 30, 2025 $49.1M
Sga Expense Q3 2025 · Sep 30, 2025 $139.5M
Sga Expense Q3 2025 · Sep 30, 2024 $46.4M
Sga Expense Q3 2025 · Sep 30, 2024 $127.48M
Rd Expense Q3 2025 · Sep 30, 2025 $24.17M
Rd Expense Q3 2025 · Sep 30, 2025 $62.24M
Rd Expense Q3 2025 · Sep 30, 2024 $26.06M
Rd Expense Q3 2025 · Sep 30, 2024 $76.41M
Net Income Q3 2025 · Sep 30, 2025 $18.44M
Net Income Q3 2025 · Sep 30, 2025 $44.81M
Net Income Q3 2025 · Jun 30, 2025 $17.83M
Net Income Q3 2025 · Mar 31, 2025 $8.54M
Net Income Q3 2025 · Sep 30, 2024 −$12.69M
Net Income Q3 2025 · Sep 30, 2024 −$34.31M
Net Income Q3 2025 · Jun 30, 2024 −$3.91M
Net Income Q3 2025 · Mar 31, 2024 −$17.7M
Operating Income Q3 2025 · Sep 30, 2025 $24.02M
Operating Income Q3 2025 · Sep 30, 2025 $57.45M
Operating Income Q3 2025 · Sep 30, 2024 −$9.66M
Operating Income Q3 2025 · Sep 30, 2024 −$26.32M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $20.26M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $56.73M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $20.11M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $43.01M
Revenue Q3 2025 · Sep 30, 2025 $180.86M
Revenue Q3 2025 · Sep 30, 2025 $475.44M
Revenue Q3 2025 · Sep 30, 2024 $112.21M
Revenue Q3 2025 · Sep 30, 2024 $300.7M